AMP-Activated Protein Kinase: Potential Target for TNBC AMP-Activated Protein Kinase: Potential Target for TNBC
Metformin, fluoxetine, and other AMPK agonists significantly inhibit TNBC. Will targeted therapy finally become an option for this aggressive disease?Breast Cancer Research
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Fluoxetine | Fortamet | Health | Hematology | Metformin | Prozac